We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

MedImaging

Download Mobile App
Recent News Radiography MRI Ultrasound Nuclear Medicine General/Advanced Imaging Imaging IT Industry News

Research Shows Effectiveness of Stereotactic Body Radiotherapy for Spinal Tumors

By MedImaging International staff writers
Posted on 02 Sep 2009
Stereotactic body radiotherapy (SBRT) has been shown to be a highly effective alternative treatment for some cancer patients with spinal metastases, according to a new study.

"These data confirm the established method of cancer treatment used on spinal tumors and other hard to reach areas of the body, due to the precisely targeted radiation dose and noninvasive nature of radiosurgery,” said James G. Schwade, M.D., from the University of Texas in Houston (USA), and executive director of the CyberKnife Centers of Miami and Palm Beach, FL, USA.

Dr. Schwade's study was presented at the American Association of Neurological Surgeons annual meeting in San Diego, CA, USA, in August 2009. "SBRT offers patients a minimally invasive treatment option they previously did not have,” said Dr. Eric L. Chang. "We are also able to offer patients a degree of pain control and to decrease their pain medications, minimizing the side effects from those medications.”

In the study, researchers evaluated 121 cancer patients with metastases to the spine who underwent intensity-modulated, near simultaneous, computed tomography (CT) image-guided SBRT, according to Dr. Chang. Researchers used a stereotactic body frame system consisting of a whole-body vacuum cushion and plastic fixation sheet used to immobilize patients for the treatment period, which lasts approximately one hour.

The team performed magnetic resonance (MR) imaging of the spine within 30 days of patient enrollment, every three months for the first year, and every six months after that. Patients also evaluated their own pain and other discomfort using instruments including the validated Brief Pain Inventory and the M.D. Anderson [Houston, TX, USA] Symptom Inventory.

Related Links:
University of Texas in Houston





Ultrasound-Guided Biopsy & Visualization Tools
Endoscopic Ultrasound (EUS) Guided Devices
High-Precision QA Tool
DEXA Phantom
New
Digital Color Doppler Ultrasound System
MS22Plus
New
Mobile X-Ray System
K4W

Latest Radiography News

AI Hybrid Strategy Improves Mammogram Interpretation
02 Sep 2009  |   Radiography

AI Technology Predicts Personalized Five-Year Risk of Developing Breast Cancer
02 Sep 2009  |   Radiography

RSNA AI Challenge Models Can Independently Interpret Mammograms
02 Sep 2009  |   Radiography